Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00544999 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: everolimus
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Institut de Recherche Clinique sur les Cancers et le Sang